ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

US News

Alibaba: "Open Says Me" - Weibo: "Me Too!"

18 Mar 2014 @ 15:38
How would you answer if I asked you, “Who is is largest e-commerce company in the world, measured by the amount of business transacted?” Would you pick Amazon or eBay? Or, thinking that I was asking a trick question, would you go with Google? It really doesn’t matter, because if you named one of those […]
 

Exide lands US defence contract

17 Mar 2014 @ 21:34
Exide Technologies (OTCQB:XIDEQ), a global leader in stored electrical-energy solutions, announced today that the company has secured a new supply contract for storage batteries with the Defense Logistics Agency (DLA) Land and Maritime, Columbus, Ohio. The DLA is the U.S. Department of Defense’s largest logistics combat support agency, providing worldwide logistics support, acquisition...
 

eFuture announces unaudited Q4 and FY 2013 results

17 Mar 2014 @ 21:31
Chinese New Year? eFuture Information Technology Inc. (Nasdaq:EFUT), a provider of software and services in China’s rapidly growing retail and consumer goods industries, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2013. Full Year 2013 Financial Highlights: – Total revenue increased 0.4% year-over-year to RMB199.2 million...
 

Sucampo and Takeda announce update on liquid formulation

16 Mar 2014 @ 10:26
H20? Sucampo Pharma Americas, LLC, a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), and its development and commercialization partner’s subsidiary Takeda Pharmaceuticals U.S.A., Inc. have announced that the New Drug Application (NDA) for the liquid formulation of AMITIZA (lubiprostone) will not be filed in the second half of 2014. In preliminary pre-NDA...
 

Coastal announce 2014 Q1 results

16 Mar 2014 @ 10:21
Coastal Contacts (Nasdaq:COA) (TSX:COA), a global manufacturer and digital retailer of high-quality glasses and contact lenses, reported financial results for the first fiscal quarter ended January 31, 2014. Total sales in the first quarter were $52.1 million compared to $54.9 million in the same year-ago quarter. Gross profit was $22.6 million, or 43% of sales, […]
 

Intercept release 2013 results

15 Mar 2014 @ 10:15
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) , a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver and intestinal diseases, has reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on key development programs. Summary of Key Programs, […]
 

BP Is Now ‘More Investable'

14 Mar 2014 @ 15:17
Lucy MacDonald, who manages some $7.3 billion in assets in her position as CIO of Allianz Global Investors, has declared that BP (LSE:BP.) (NYSE:BP) is now “more investable” as a result of the company’s entering into an administrative agreement with the U.S. Environmental Protection Agency four years past the Deepwater Horizon catastrophe in the Gulf […]
 

Firsthand Technology Value Fund announce 2013 FY results

14 Mar 2014 @ 10:37
NAV of $28.32 per Share Firsthand Technology Value Fund, Inc. (Nasdaq:SVVC), a publicly-traded venture capital fund that invests in technology and cleantech companies, has announced financial results for the fiscal year ended December 31, 2013. As of December 31, 2013, the Fund’s net assets were approximately $256.9 million, or $28.32 per share, compared with net […]
 

Digirad acquires Telerhythmics

14 Mar 2014 @ 10:34
Outsourced cardiac monitoring service for physicians and hospitals Digirad Corporation (Nasdaq:DRAD), a provider of diagnostic imaging services and technology has announced that it has acquired all the outstanding membership interest of Telerhythmics, LLC, a 24-hour cardiac event monitoring service used on an outsourced basis by hospitals and physician offices. Based in Memphis, Tennessee...
 

Martin Midstream Partners annunce $150m add-on

14 Mar 2014 @ 10:32
Martin Midstream Partners L.P. (Nasdaq:MMLP) have announced that it and its wholly-owned subsidiary, Martin Midstream Finance Corp., priced the offering of $150 million in aggregate principal amount of 7.250% senior unsecured notes due 2021 at an issue price of 103.000%, plus accrued interest from February 15, 2014. The additional notes are being sold as an […]
 
 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com